Condition
Maternal Hypertension
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Recruiting2
Terminated1
Completed1
Not Yet Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05726279Not ApplicableTerminated
PROtecting Maternal Brains From Injury and Stroke
NCT05551104Phase 3Recruiting
Safest Choice of Antihypertensive Regimen for Postpartum Hypertension
NCT05881252CompletedPrimary
Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension
NCT04766866Not ApplicableRecruiting
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
NCT06344702Not Yet RecruitingPrimary
The Effect of CPAP on Maternal and Infant Outcomes in Pregnant Women With OSAS
Showing all 5 trials